We are monitoring the impact of COVID-19 on Europe Synthetic Biology Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 7559
Share on
Share on

Europe Synthetic Biology Market Research Report – Segmented By Tool, Technology, Application, Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis on Size, Share, Growth, Trends, Forecasts (2020 to 2025)

Pulished: February, 2020
ID: 7559
Pages: 145

Europe Synthetic Biology Market Size (2020 to 2025)

The size of the Synthetic Biology Market in Europe was worth USD 1.39 billion in 2020 and is projected to grow at a CAGR of 23.21%, to reach USD 3.93 billion by 2025.

The rise in the large-scale applications such as the capacity to produce or create new, and correcting and carrying out of a gene are the factors driving the European synthetic biology market. This is also driven by factors like heavy use of substance formed by a living organism to create a catalyst kit, gene synthesis products in academics or during the studies. The extensive usage of investigation of introduced and more desirable treatments, the quality of being able to private and public funding for the discovery of novel therapies, is the main driver for the Europe synthetic biology market.

Production or modification of living organisms, heredity material, biological systems, rise in research activities which form as a whole substance from two, of science, technology and engineering to design, redesign or produce will create new opportunities for the players in the industry during the forecast period. In the Europe region, rise in focus is because of the low price of the medicinal drugs that are prepared using machinery advantage provides opportunities for manufacturers.

As synthetic biology has an excellent capability, some factors hamper the market growth like government policies, i.e., which are being regulated or related bio-war, biosafety and biosecurity issues. Competition or the increasing attempts to establish one’s superiority among the current market players may hamper the growth. Ethical risk also hinders the development of Europe synthetic biology market.

Advance use of operations of computers and design systems in synthetic biology have changed the traditional approach of fighting against the genetic problems and new diseases. A few years back, to reach a specific rate or level, bio-based economy, are around making benefits in the regulatory environment of the market. In order to translate research and development into profits and the ability to work successfully and to rate the technology, there is a need to build the required infrastructure, which will be a challenging factor.

This research report has been segmented & sub-segmented into the following categories:

  • By Tool: Chassis Organisms, Cloning & Assembly Kits, Oligonucleotide Synthesis, Enzymes and Xeno Nucleic Acid
  • By Technology: Enabling technologies (Gene Synthesis, Cloning and Sequencing, Genome Engineering, Bioinformatics, Nanotechnology, Site-Directed Mutagenesis, Microfluidics & Measurement and Modeling) and Enabled technologies (Next-Generation Sequencing & Pathway Engineering)
  • By Application: Medical, Environmental and Industrial
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

On the basis of region, Europe occupies the second highest market share and is expected to continue holding that position during the forecast period.

Key market participants in the European Synthetic Biology market profiled in this report are Dupont, Intrexon Corporation, Amyris, Inc., Genscript USA, Inc., Integrated Dna Technologies (IDT), Inc., Novozymes, Royal DSM N.V, New England Biolabs, Inc., Synthetic Genomics, Inc. and Thermo Fisher Scientific, Inc.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Tools                             

                                5.1.1 Introduction           

                                5.1.2 Chassis Organisms               

                                5.1.3 Cloning and Assembly kits

                                5.1.4 Oligonucleotide Synthesis

                                5.1.5 Enzymes  

                                5.1.6 Xeno Nucleic Acid

                                5.1.7  Y-o-Y Growth Analysis, By Tool      

                                5.1.8  Market Attractiveness Analysis, By Tool    

                                5.1.9  Market Share Analysis, By Tool     

                5.2 Technology                 

                                5.2.1 Introduction           

                                5.2.2 Enabling technologies        

                                                5.2.2.1 Gene Synthesis

                                                5.2.2.2 Cloning and Sequencing

                                                5.2.2.3 Genome Engineering

                                                5.2.2.4 Bioinformatics

                                                5.2.2.5 Nanotechnology

                                                5.2.2.6 Site-Directed Mutagenesis

                                                5.2.2.7 Microfluidics

                                                5.2.2.8 Measurement and Modeling

                                5.2.3 Enabled technologies         

                                                5.2.3.1 Next-Generation Sequencing

                                                5.2.3.2 Pathway Engineering

                                5.2.4 Y-o-Y Growth Analysis, By Technology        

                                5.2.5 Market Attractiveness Analysis, By Technology      

                                5.2.6 Market Share Analysis, By Technology        

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Medical Applications           

                                5.3.3 Environmental Applications             

                                5.3.4 Industrial Applications        

                                5.3.5 Y-o-Y Growth Analysis, By Application         

                                5.3.6  Market Attractiveness Analysis, By Application      

                                5.3.7  Market Share Analysis, By Application       

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Tool

                                                6.1.3.3 By Technology

                                                6.1.3.4 By Application

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Tool

                                                6.1.4.3 By Technology

                                                6.1.4.4 By Application

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Tool

                                                6.1.5.3 By Technology

                                                6.1.5.4 By Application

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Dupont                         

                                8.1.1 Overview 

                                8.1.2 Tool Analysis          

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Intrexon Corporation                             

                8.3 Amyris, Inc.                

                8.4 Genscript USA, Inc.                 

                8.5 Integrated Dna Technologies                              

                8.6 Novozymes                

                8.7 Royal DSM N.V                          

                8.8 New England Biolabs                              

                8.9 Synthetic Genomics                

                8.10 Thermo Fisher Scientific                     

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms by technology and application with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. Europe Synthetic Biology Market By Tool, From 2020 to 2025 (USD Billion)
  2. Europe Chassis Organisms Market By Region, From 2020 to 2025 (USD Billion)
  3. Europe Cloning and Assembly kits Market By Region, From 2020 to 2025 (USD Billion)
  4. Europe Oligonucleotide Synthesis Market By Region, From 2020 to 2025 (USD Billion)
  5. Europe Enzymes Market By Region, From 2020 to 2025 (USD Billion)
  6. Europe Xeno Nucleic Acid Market By Region, From 2020 to 2025 (USD Billion)
  7. Europe Synthetic Biology Market By Technology, From 2020 to 2025 (USD Billion)
  8. Europe Enabling technologies Market By Region, From 2020 to 2025 (USD Billion)
  9. Europe Enabled Technologies Market By Region, From 2020 to 2025 (USD Billion)
  10. Europe Synthetic Biology Market By Application, From 2020 to 2025 (USD Billion)
  11. Europe Medical Applications Market By Region, From 2020 to 2025 (USD Billion)
  12. Europe Environmental Applications Market By Region, From 2020 to 2025 (USD Billion)
  13. Europe Industrial Applications Market By Region, From 2020 to 2025 (USD Billion)
  14. U.K. Synthetic Biology Market By Tool, From 2020 to 2025 (USD Billion)
  15. U.K. Synthetic Biology Market By Technology, From 2020 to 2025 (USD Billion)
  16. U.K. Synthetic Biology Market By Application, From 2020 to 2025 (USD Billion)
  17. Germany Synthetic Biology Market By Tool, From 2020 to 2025 (USD Billion)
  18. Germany Synthetic Biology Market By Technology, From 2020 to 2025 (USD Billion)
  19. Germany Synthetic Biology Market By Application, From 2020 to 2025 (USD Billion)
  20. France Synthetic Biology Market By Tool, From 2020 to 2025 (USD Billion)
  21. France Synthetic Biology Market By Technology, From 2020 to 2025 (USD Billion)
  22. France Synthetic Biology Market By Application, From 2020 to 2025 (USD Billion)
  23. Italy Synthetic Biology Market By Tool, From 2020 to 2025 (USD Billion)
  24. Italy Synthetic Biology Market By Technology, From 2020 to 2025 (USD Billion)
  25. Italy Synthetic Biology Market By Application, From 2020 to 2025 (USD Billion)
  26. Spain Synthetic Biology Market By Tool, From 2020 to 2025 (USD Billion)
  27. Spain Synthetic Biology Market By Technology, From 2020 to 2025 (USD Billion)
  28. Spain Synthetic Biology Market By Application, From 2020 to 2025 (USD Billion)
  29. Europe Synthetic Biology Market By Enabling technologies, From 2020 to 2025 (USD Billion)
  30. Europe Gene Synthesis Market By Region, From 2020 to 2025 (USD Billion)
  31. Europe Cloning and Sequencing Market By Region, From 2020 to 2025 (USD Billion)
  32. Europe Genome Engineering Market By Region, From 2020 to 2025 (USD Billion)
  33. Europe Bioinformatics Market By Region, From 2020 to 2025 (USD Billion)
  34. Europe Nanotechnology Market By Region, From 2020 to 2025 (USD Billion)
  35. Europe Site-Directed Mutagenesis Market By Region, From 2020 to 2025 (USD Billion)
  36. Europe Microfluidics Market By Region, From 2020 to 2025 (USD Billion)
  37. Europe Measurement and Modeling Market By Region, From 2020 to 2025 (USD Billion)
  38. U.K. Synthetic Biology Market By Enabling technologies, From 2020 to 2025 (USD Billion)
  39. Germany Synthetic Biology Market By Enabling technologies, From 2020 to 2025 (USD Billion)
  40. France Synthetic Biology Market By Enabling technologies, From 2020 to 2025 (USD Billion)
  41. Italy Synthetic Biology Market By Enabling technologies, From 2020 to 2025 (USD Billion)
  42. Spain Synthetic Biology Market By Enabling technologies, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample